Marjolein Smidt

8PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsCancer diagnosisPredictive and prognostic markersImplementation science and evaluation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 06, 2025
The gut microbiota during tamoxifen therapy in patients with breast cancer.

Lars E Hillege, David J M Barnett, Janine Ziemons

|Nov 13, 2024
The role of gut microbial β-glucuronidases in carcinogenesis and cancer treatment: a scoping review.

Lars E Hillege, Milou A M Stevens, Paulien A J Kristen

|Aug 27, 2024
Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance.

Mieke R Van Bockstal, Jelle Wesseling, Ester H Lips

|Jun 25, 2024
Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon.

Janine Ziemons, Lars E Hillege, Romy Aarnoutse

|Oct 04, 2023
Gene expression profiles in clinically T1-2N0 ER+HER2- breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performed.

L M van Roozendaal, M L G Vane, E Colier

|Apr 07, 2023
Fecal levels of SCFA and BCFA during capecitabine in patients with metastatic or unresectable colorectal cancer.

Janine Ziemons, Romy Aarnoutse, Anne Heuft

Pageof 2

Frequent Collaborators

4 joint publications

John Penders

4 joint publications

Judith de Vos-Geelen

4 joint publications

Lars Hillege

3 joint publications

Janine Ziemons